A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers
暂无分享,去创建一个
K. Do | A. Lok | F. Stingo | Ziding Feng | N. Tayob
[1] Daniel Neuhoff,et al. Reversible Jump Markov Chain Monte Carlo , 2016 .
[2] K. Do,et al. Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] Mariel S. Lavieri,et al. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] C. Berg,et al. Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Timothy R Morgan,et al. Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C , 2012, The American Journal of Gastroenterology.
[6] J. Marrero,et al. Patient Involvement in Healthcare is Associated With Higher Rates of Surveillance for Hepatocellular Carcinoma , 2011, Journal of clinical gastroenterology.
[7] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[8] William M. Lee,et al. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. , 2011, Gastroenterology.
[9] William M. Lee,et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. , 2010, Gastroenterology.
[10] E. Bass,et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review , 2002, Hepatology.
[11] D. Pauler,et al. Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers , 2001 .
[12] S. Chib. Estimation and comparison of multiple change-point models , 1998 .
[13] P. Green. Reversible jump Markov chain Monte Carlo computation and Bayesian model determination , 1995 .
[14] G. Dusheiko,et al. Management of hepatocellular carcinoma. , 1992, Journal of hepatology.
[15] Michelle Norris,et al. Modeling bivariate longitudinal diagnostic outcome data in the absence of a gold standard , 2009 .
[16] N. Urban,et al. A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker. , 2003, Biostatistics.
[17] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.